Structured evidence table for Alpha-Lipoic Acid Cardiometabolic Markers Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Alpha-Lipoic Acid Cardiometabolic Markers Randomized Trial | It is often associated with hormonal imbalance, metabolic disturbances, and reproductive complications, which together contribute to an elevated risk of long-term cardiometabolic disorders. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Alpha-Lipoic Acid Cardiometabolic Markers Randomized Trial | To narratively synthesize mechanistic rationale and human clinical evidence on dietary seeds and selected nutraceuticals relevant to PCOS, with emphasis on metabolic and reproductive endpoints of interest to nutrition and obstetrics/gynecology practice. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Alpha-Lipoic Acid Cardiometabolic Markers Randomized Trial | Proposed "seed cycling" protocols have received attention, yet most clinical data are derived from mixed-seed supplementation studies or low-level evidence, such as case reports, and should be considered hypothesis-generating. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Alpha-Lipoic Acid Cardiometabolic Markers Randomized Trial | Polycystic ovary syndrome (PCOS) represents one of the most common endocrine disorders among women of reproductive age. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
Source documents